Glenn Yiu, MD, PhD

Clinical Advisor, Neuro-ophthalmology

• Clinician-scientist specializing in medical and surgical management of retinal diseases at UC Davis.

Dr. Glenn Yiu is a Professor of Ophthalmology at UC Davis. He earned his dual MD-PhD degrees at Harvard Medical School, residency training at the Massachusetts Eye & Ear Infirmary, and vitreoretinal fellowship at Duke. He joined UC Davis as a clinician-scientist and vitreoretinal surgeon in 2014, where he now leads a translational research program studying age-related macular degeneration (AMD) and other retinal diseases. His focuses include ocular imaging technologies, gene editing and delivery, and animal models of retinal disease. He reported the first use of CRISPR-based genome editing as a treatment strategy for wet AMD, discovered the use of microneedles for suprachoroidal gene delivery, and pioneered important studies on drusen evolution in rhesus monkeys. He currently serves as Director of the UC Davis Reading Center and Director of Tele-ophthalmology, where he has pioneered a teleretinal screening program to expand eye screening among diabetic patients in Northern California. Dr. Yiu has published numerous peer-reviewed scientific articles and book chapters, and is the editor of the textbook “Vitreoretinal Disorders.” He also serves on the editorial board of Scientific Reports and Frontiers in Genome Editing, as a member of the ARVO Annual Meeting Program Committee, and as a course lecturer at the American Academy of Ophthalmology. He has received numerous awards including the Ronald G. Michels Fellowship, the Heed Fellowship, the Retina Society Fellowship Research Award, the Macula Society Evangelos S. Gragoudas Award, and most recently, the ARVO Carl Camras Translational Research Award in 2024.